Genenta Science股价因战略性LVV质粒DNA合作而飙升

Investing.com -- Genenta Science (NASDAQ:GNTA) 股价在周五盘前交易中飙升241.8%，此前该公司宣布与ANEMOCYTE达成战略合作，专注于现成的慢病毒载体质粒DNA技术。 这一合作扩展了两家公司之间现有的关系，此前双方合作主要集中在质粒DNA生产方面。根据新协议，Genenta将向ANEMOCYTE及其客户提供其经临床验证的LVV质粒DNA技术平台。
InvestorsHub on MSN

Applied DNA Stock Surges on $27 Million PIPE Financing Deal

Applied DNA Sciences Inc. (NASDAQ:BNBX) saw its shares soar 50% in pre-market trading on Wednesday after the biotech firm ...

Genenta Science stock soars on strategic LVV Plasmid DNA collaboration

Investing.com -- Genenta Science (NASDAQ:GNTA) stock soared 241.8% in premarket trading Friday after announcing a strategic collaboration with ANEMOCYTE focused on off-the-shelf lentiviral vector ...

Applied DNA stock soars after closing $27 million PIPE financing

Investing.com -- Applied DNA Sciences Inc (NASDAQ:BNBX) stock surged 50% in premarket trading Wednesday after the biotechnology company announced the successful closing of a private investment in ...

Little-Known Tech CEO Says Her Company ‘Shares the Same DNA as Palantir.’ Should You ...

We share the same disruptive DNA – reimagining the foundations of our industries to help others do the same,” Lumen CEO Kate ...

BNB treasury race accelerates as Applied DNA, CEA Industries expand holdings

Applied DNA Sciences and CEA Industries disclosed new BNB purchases as publicly traded firms increase exposure to Binance’s ...

DNA Holdings Orchestrates Landmark $344.4M Capital Deal, Bridging Nasdaq-Listed Company ...

The transaction represents one of the first times Wall Street capital has been directly aligned with decentralized AI ...